Literature DB >> 21663971

Periprosthetic joint infection following Staphylococcus aureus bacteremia.

Parham Sendi1, Florian Banderet, Peter Graber, Werner Zimmerli.   

Abstract

OBJECTIVES: The incidence of haematogenous periprosthetic joint infections (PJI) among patients with remote infections has been reported to be less than 1%. This incidence may be much higher in cases after documented Staphylococcus aureus bacteremia (SAB). We evaluated the incidence of haematogenous PJI following SAB in patients with previously uninfected arthroplasties.
METHODS: A retrospective analysis of our cohort including patients with SAB and prosthetic joints at the Basel University Medical Clinic Liestal from 1998 to 2008.
RESULTS: We identified 31 patients with 45 uninfected prosthetic joints in situ at the time of SAB. In 12 patients (39%) and 13 arthroplasties (29%), SAB caused PJI. In comparison to nosocomial SAB, infections occurred only in cases with community-acquired SAB (p=0.002). PJI was diagnosed within a median time of 2.5 days (IQR 1-3.5) after admission. The comparison between patients with and without PJI revealed no significant difference in gender, age, comorbidities and number of prostheses per patient and age of the prosthesis.
CONCLUSIONS: The rate of PJI after SAB is high, ranging from 30% to 40%, and clearly higher than rates reported for bacteremia with other pathogens. PJIs were observed in community-onset bacteremia, in which there is a typically delay from symptoms to antimicrobial treatment.
Copyright © 2011 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21663971     DOI: 10.1016/j.jinf.2011.05.005

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  35 in total

Review 1.  Pathogenesis of implant-associated infection: the role of the host.

Authors:  Werner Zimmerli; Parham Sendi
Journal:  Semin Immunopathol       Date:  2011-05-21       Impact factor: 9.623

2.  Has the rate of in-hospital infections after total joint arthroplasty decreased?

Authors:  Mohammad R Rasouli; Mitchell Gil Maltenfort; James J Purtill; William J Hozack; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2013-10       Impact factor: 4.176

3.  Remission after treatment of osteoarticular infections due to Pseudomonas aeruginosa versus Staphylococcus aureus: a case-controlled study.

Authors:  Khalid Seghrouchni; Christian van Delden; Dennis Dominguez; Mohamed Benkabouche; Louis Bernard; Mathieu Assal; Pierre Hoffmeyer; Ilker Uçkay
Journal:  Int Orthop       Date:  2011-10-05       Impact factor: 3.075

4.  Total knee arthroplasty in patients with a history of illicit intravenous drug abuse.

Authors:  David E Bauer; Andreas Hingsammer; Lukas Ernstbrunner; Alexander Aichmair; Andrea B Rosskopf; Franziska Eckers; Karl Wieser; Sandro F Fucentese
Journal:  Int Orthop       Date:  2017-10-14       Impact factor: 3.075

Review 5.  [Antibiotic stewardship and Staphylococcus aureus Bacteremia].

Authors:  S Weis; A Kimmig; S Hagel; M W Pletz
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-04-04       Impact factor: 0.840

6.  Mouse model of hematogenous implant-related Staphylococcus aureus biofilm infection reveals therapeutic targets.

Authors:  Yu Wang; Lily I Cheng; David R Helfer; Alyssa G Ashbaugh; Robert J Miller; Alexander J Tzomides; John M Thompson; Roger V Ortines; Andrew S Tsai; Haiyun Liu; Carly A Dillen; Nathan K Archer; Taylor S Cohen; Christine Tkaczyk; C Kendall Stover; Bret R Sellman; Lloyd S Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-12       Impact factor: 11.205

7.  Clinical spectrum and outcome of critically ill patients suffering from prosthetic joint infections.

Authors:  Y Maaloum; A Meybeck; D Olive; N Boussekey; P-Y Delannoy; A Chiche; H Georges; E Beltrand; E Senneville; T d'Escrivan; O Leroy
Journal:  Infection       Date:  2012-10-25       Impact factor: 3.553

Review 8.  Infection Prevention Considerations for Complex Penile Prosthesis Recipients.

Authors:  Robert J Carrasquillo; Ricardo M Munarriz; Martin S Gross
Journal:  Curr Urol Rep       Date:  2019-02-01       Impact factor: 3.092

9.  A Methyl 4-Oxo-4-phenylbut-2-enoate with in Vivo Activity against MRSA that Inhibits MenB in the Bacterial Menaquinone Biosynthesis Pathway.

Authors:  Joe S Matarlo; Yang Lu; Fereidoon Daryaee; Taraneh Daryaee; Bela Ruzsicska; Stephen G Walker; Peter J Tonge
Journal:  ACS Infect Dis       Date:  2016-03-07       Impact factor: 5.084

10.  Preventing Implant-Associated Infections by Silver Coating.

Authors:  Richard Kuehl; Priscilla S Brunetto; Anne-Kathrin Woischnig; Massimo Varisco; Zarko Rajacic; Juerg Vosbeck; Luigi Terracciano; Katharina M Fromm; Nina Khanna
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.